 | • レポートコード：QYR9ST05058 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、TNF阻害剤の世界市場について調査・分析し、TNF阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（単独療法、併用療法）、用途別（皮膚病、強直性脊椎炎、胃腸疾患、関節リウマチ、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のTNF阻害剤市場動向 ・主要企業別マーケットシェア ・TNF阻害剤の種類別市場規模2014-2019 （単独療法、併用療法） ・TNF阻害剤の用途別市場規模2014-2019 （皮膚病、強直性脊椎炎、胃腸疾患、関節リウマチ、その他） ・TNF阻害剤の北米市場：主要企業・種類別/用途別市場規模 ・TNF阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・TNF阻害剤の中国市場：主要企業・種類別/用途別市場規模 ・TNF阻害剤の日本国内市場：主要企業・種類別/用途別市場規模 ・TNF阻害剤の東南アジア市場：主要企業・種類別/用途別市場規模 ・TNF阻害剤のインド市場：主要企業・種類別/用途別市場規模 ・TNF阻害剤の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Novartis、Boehringer Ingelheim、Amgen、BioPharma、Mochida Pharmaceutical、Hanall） ・TNF阻害剤の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflammation-causing substance. TNF inhibitor drugs are employed to treat inflammatory conditions such as rheumatoid arthritis and juvenile arthritis. Generally, in the healthy person, the TNF levels remain steady. However, in a patient with rheumatoid arthritis, the level of TNF is increasing which leads to more inflammation. TNF inhibitor drugs act as blockers for TNF substances. TNF alpha blockers are highly effective in the treatment of patients with active rheumatoid arthritis. These drugs are used in patients as a conventional second-line treatments.The adalimumab segment is likely to expand at a significant pace during the forecast period. The drug is effectively used in a broad range of pain management therapies and is widely available over the counter. Based on distribution channel, the TNF inhibitors market can be segmented into hospital pharmacy and retail pharmacy. The hospital pharmacy segment is likely to expand at a significant pace between 2017 and 2025, this is because patients with rheumatoid arthritis, arthritis give more preference to the hospitals for treatment. Increase in elderly population and rise in the prevalence of rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease are some of the factors that drive the TNF inhibitors market. According to the National Health Interview Survey, in 2016, almost 20% of the global population was reported to be suffering from chronic pain, with rheumatoid arthritis being one of the major reasons. Moreover, according to the Center for Disease Control and Prevention, by 2040, approximately 78 million (26%) of the U.S. adults are projected to have arthritis. Owing to this, the consumption of TNF inhibitor dugs is likely to increase rapidly in the near future. However, side-effects associated with the use of TNF inhibitor drugs such as skin irritation, flushing, headache, and abdominal pain are estimated to hinder the market in the next few years.
In 2018, the global TNF Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global TNF Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the TNF Inhibitors development in United States, Europe and China.
The key players covered in this study
Pfizer
Novartis
Boehringer Ingelheim
Amgen
BioPharma
Mochida Pharmaceutical
Hanall
…
Market segment by Type, the product can be split into
Monotherapy
Combination Therapy
Market segment by Application, split into
Skin Disease
Ankylosing Spondylitis
Gastrointestinal Disease
Rheumatoid Arthritis
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global TNF Inhibitors status, future forecast, growth opportunity, key market and key players.
To present the TNF Inhibitors development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of TNF Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global TNF Inhibitors Market Size Growth Rate by Type (2014-2025)
1.4.2 Monotherapy
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global TNF Inhibitors Market Share by Application (2014-2025)
1.5.2 Skin Disease
1.5.3 Ankylosing Spondylitis
1.5.4 Gastrointestinal Disease
1.5.5 Rheumatoid Arthritis
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 TNF Inhibitors Market Size
2.2 TNF Inhibitors Growth Trends by Regions
2.2.1 TNF Inhibitors Market Size by Regions (2014-2025)
2.2.2 TNF Inhibitors Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 TNF Inhibitors Market Size by Manufacturers
3.1.1 Global TNF Inhibitors Revenue by Manufacturers (2014-2019)
3.1.2 Global TNF Inhibitors Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global TNF Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2 TNF Inhibitors Key Players Head office and Area Served
3.3 Key Players TNF Inhibitors Product/Solution/Service
3.4 Date of Enter into TNF Inhibitors Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global TNF Inhibitors Market Size by Type (2014-2019)
4.2 Global TNF Inhibitors Market Size by Application (2014-2019)
5 United States
5.1 United States TNF Inhibitors Market Size (2014-2019)
5.2 TNF Inhibitors Key Players in United States
5.3 United States TNF Inhibitors Market Size by Type
5.4 United States TNF Inhibitors Market Size by Application
6 Europe
6.1 Europe TNF Inhibitors Market Size (2014-2019)
6.2 TNF Inhibitors Key Players in Europe
6.3 Europe TNF Inhibitors Market Size by Type
6.4 Europe TNF Inhibitors Market Size by Application
7 China
7.1 China TNF Inhibitors Market Size (2014-2019)
7.2 TNF Inhibitors Key Players in China
7.3 China TNF Inhibitors Market Size by Type
7.4 China TNF Inhibitors Market Size by Application
8 Japan
8.1 Japan TNF Inhibitors Market Size (2014-2019)
8.2 TNF Inhibitors Key Players in Japan
8.3 Japan TNF Inhibitors Market Size by Type
8.4 Japan TNF Inhibitors Market Size by Application
9 Southeast Asia
9.1 Southeast Asia TNF Inhibitors Market Size (2014-2019)
9.2 TNF Inhibitors Key Players in Southeast Asia
9.3 Southeast Asia TNF Inhibitors Market Size by Type
9.4 Southeast Asia TNF Inhibitors Market Size by Application
10 India
10.1 India TNF Inhibitors Market Size (2014-2019)
10.2 TNF Inhibitors Key Players in India
10.3 India TNF Inhibitors Market Size by Type
10.4 India TNF Inhibitors Market Size by Application
11 Central & South America
11.1 Central & South America TNF Inhibitors Market Size (2014-2019)
11.2 TNF Inhibitors Key Players in Central & South America
11.3 Central & South America TNF Inhibitors Market Size by Type
11.4 Central & South America TNF Inhibitors Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 TNF Inhibitors Introduction
12.1.4 Pfizer Revenue in TNF Inhibitors Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 TNF Inhibitors Introduction
12.2.4 Novartis Revenue in TNF Inhibitors Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Company Details
12.3.2 Company Description and Business Overview
12.3.3 TNF Inhibitors Introduction
12.3.4 Boehringer Ingelheim Revenue in TNF Inhibitors Business (2014-2019)
12.3.5 Boehringer Ingelheim Recent Development
12.4 Amgen
12.4.1 Amgen Company Details
12.4.2 Company Description and Business Overview
12.4.3 TNF Inhibitors Introduction
12.4.4 Amgen Revenue in TNF Inhibitors Business (2014-2019)
12.4.5 Amgen Recent Development
12.5 BioPharma
12.5.1 BioPharma Company Details
12.5.2 Company Description and Business Overview
12.5.3 TNF Inhibitors Introduction
12.5.4 BioPharma Revenue in TNF Inhibitors Business (2014-2019)
12.5.5 BioPharma Recent Development
12.6 Mochida Pharmaceutical
12.6.1 Mochida Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 TNF Inhibitors Introduction
12.6.4 Mochida Pharmaceutical Revenue in TNF Inhibitors Business (2014-2019)
12.6.5 Mochida Pharmaceutical Recent Development
12.7 Hanall
12.7.1 Hanall Company Details
12.7.2 Company Description and Business Overview
12.7.3 TNF Inhibitors Introduction
12.7.4 Hanall Revenue in TNF Inhibitors Business (2014-2019)
12.7.5 Hanall Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table TNF Inhibitors Key Market Segments
Table Key Players TNF Inhibitors Covered
Table Global TNF Inhibitors Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global TNF Inhibitors Market Size Market Share by Type 2014-2025
Figure Monotherapy Figures
Table Key Players of Monotherapy
Figure Combination Therapy Figures
Table Key Players of Combination Therapy
Table Global TNF Inhibitors Market Size Growth by Application 2014-2025 (Million US$)
Figure Skin Disease Case Studies
Figure Ankylosing Spondylitis Case Studies
Figure Gastrointestinal Disease Case Studies
Figure Rheumatoid Arthritis Case Studies
Figure Others Case Studies
Figure TNF Inhibitors Report Years Considered
Table Global TNF Inhibitors Market Size 2014-2025 (Million US$)
Figure Global TNF Inhibitors Market Size and Growth Rate 2014-2025 (Million US$)
Table Global TNF Inhibitors Market Size by Regions 2014-2025 (Million US$)
Table Global TNF Inhibitors Market Size by Regions 2014-2019 (Million US$)
Table Global TNF Inhibitors Market Share by Regions 2014-2019
Figure Global TNF Inhibitors Market Share by Regions 2014-2019
Figure Global TNF Inhibitors Market Share by Regions 2019
Table Market Top Trends
Table Global TNF Inhibitors Revenue by Manufacturers (2014-2019) (Million US$)
Table Global TNF Inhibitors Market Share by Manufacturers (2014-2019)
Figure Global TNF Inhibitors Market Share by Manufacturers in 2018
Table Global TNF Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players TNF Inhibitors Product/Solution/Service
Table Date of Enter into TNF Inhibitors Market
Table Mergers & Acquisitions, Expansion Plans
Table Global TNF Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Global TNF Inhibitors Market Size Share by Type (2014-2019)
Figure Global TNF Inhibitors Market Size Market Share by Type (2014-2019)
Table Global TNF Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Global TNF Inhibitors Market Size Share by Application (2014-2019)
Figure Global TNF Inhibitors Market Size Market Share by Application (2014-2019)
Figure Global TNF Inhibitors Revenue Market Share by Application in 2018
Figure United States TNF Inhibitors Market Size 2014-2019 (Million US$)
Table United States Key Players TNF Inhibitors Revenue (2018-2019) (Million US$)
Table United States Key Players TNF Inhibitors Market Share (2018-2019)
Table United States TNF Inhibitors Market Size by Type (2014-2019) (Million US$)
Table United States TNF Inhibitors Market Share by Type (2014-2019)
Table United States TNF Inhibitors Market Size by Application (2014-2019) (Million US$)
Table United States TNF Inhibitors Market Share by Application (2014-2019)
Figure Europe TNF Inhibitors Market Size 2014-2019 (Million US$)
Table Europe Key Players TNF Inhibitors Revenue (2018-2019) (Million US$)
Table Europe Key Players TNF Inhibitors Market Share (2018-2019)
Table Europe TNF Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Europe TNF Inhibitors Market Share by Type (2014-2019)
Table Europe TNF Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Europe TNF Inhibitors Market Share by Application (2014-2019)
Figure China TNF Inhibitors Market Size 2014-2019 (Million US$)
Table China Key Players TNF Inhibitors Revenue (2018-2019) (Million US$)
Table China Key Players TNF Inhibitors Market Share (2018-2019)
Table China TNF Inhibitors Market Size by Type (2014-20189) (Million US$)
Table China TNF Inhibitors Market Share by Type (2014-2019)
Table China TNF Inhibitors Market Size by Application (2014-2019) (Million US$)
Table China TNF Inhibitors Market Share by Application (2014-2019)
Figure Japan TNF Inhibitors Market Size 2014-2019 (Million US$)
Table Japan Key Players TNF Inhibitors Revenue (2018-2019) (Million US$)
Table Japan Key Players TNF Inhibitors Market Share (2018-2019)
Table Japan TNF Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Japan TNF Inhibitors Market Share by Type (2014-2019)
Table Japan TNF Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Japan TNF Inhibitors Market Share by Application (2014-2019)
Figure Southeast Asia TNF Inhibitors Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players TNF Inhibitors Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players TNF Inhibitors Market Share (2018-2019)
Table Southeast Asia TNF Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia TNF Inhibitors Market Share by Type (2014-2019)
Table Southeast Asia TNF Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia TNF Inhibitors Market Share by Application (2014-2019)
Figure India TNF Inhibitors Market Size 2014-2019 (Million US$)
Table India Key Players TNF Inhibitors Revenue (2018-2019) (Million US$)
Table India Key Players TNF Inhibitors Market Share (2018-2019)
Table India TNF Inhibitors Market Size by Type (2014-2019) (Million US$)
Table India TNF Inhibitors Market Share by Type (2014-2019)
Table India TNF Inhibitors Market Size by Application (2014-2019) (Million US$)
Table India TNF Inhibitors Market Share by Application (2014-2019)
Figure Central & South America TNF Inhibitors Market Size 2014-2019 (Million US$)
Table Central & South America Key Players TNF Inhibitors Revenue (2018-2019) (Million US$)
Table Central & South America Key Players TNF Inhibitors Market Share (2018-2019)
Table Central & South America TNF Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Central & South America TNF Inhibitors Market Share by Type (2014-2019)
Table Central & South America TNF Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Central & South America TNF Inhibitors Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in TNF Inhibitors Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in TNF Inhibitors Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in TNF Inhibitors Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in TNF Inhibitors Business (2014-2019)
Table Novartis Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in TNF Inhibitors Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in TNF Inhibitors Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Amgen Company Details
Table Amgen Revenue in TNF Inhibitors Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in TNF Inhibitors Business (2014-2019)
Table Amgen Recent Development
Table BioPharma Company Details
Table BioPharma Revenue in TNF Inhibitors Business (2014-2019)(Million US$)
Figure BioPharma Revenue Growth Rate in TNF Inhibitors Business (2014-2019)
Table BioPharma Recent Development
Table Mochida Pharmaceutical Company Details
Table Mochida Pharmaceutical Revenue in TNF Inhibitors Business (2014-2019)(Million US$)
Figure Mochida Pharmaceutical Revenue Growth Rate in TNF Inhibitors Business (2014-2019)
Table Mochida Pharmaceutical Recent Development
Table Hanall Company Details
Table Hanall Revenue in TNF Inhibitors Business (2014-2019)(Million US$)
Figure Hanall Revenue Growth Rate in TNF Inhibitors Business (2014-2019)
Table Hanall Recent Development
Table Global TNF Inhibitors Market Size by Regions (Million US$) 2019-2025
Figure Global TNF Inhibitors Market Size Share by Regions (2019-2025)
Figure Global TNF Inhibitors Market Size Share by Regions in 2025
Figure United States TNF Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Europe TNF Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure China TNF Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Japan TNF Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia TNF Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure India TNF Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America TNF Inhibitors Market Size Forecast (2019-2025)(Million USD)
Table Global TNF Inhibitors Market Size by Product (2019-2025) (Million US$)
Figure Global TNF Inhibitors Market Size by Product (2019-2025)
Figure Global TNF Inhibitors Market Size by Product in 2025
Table Global TNF Inhibitors Market Size by Application (2019-2025) (Million US$)
Figure Global TNF Inhibitors Market Size by Application (2019-2025)
Figure Global TNF Inhibitors Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
TNF阻害剤の世界市場：市場規模・現状・予測 TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…- 関節リウマチ治療薬の世界市場：市場規模・現状・予測 In 2018, the global Rheumatoid Arthritis Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Rheumatoid Arthritis Therapeutics status, future forecast, growth opportunity, ke…
- パーキンソン病治療の世界市場：市場規模・現状・予測 Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA)…
- 移植片対宿主病（GVHD）治療の世界市場：市場規模・現状・予測 Graft versus Host disease occurs after a stem cell or bone marrow transplant. High dose treatment destroy cancer cells along with that it simultaneously destroys healthy cells. Stem cell and bone marrow transplant treatments are used in reconstructing damaged cells, surrounding cancer tumors. Normal…
- アルツハイマー病治療薬の世界市場：市場規模・現状・予測 Alzheimer’s disease is a neurodegenerative, progressive, non-reversible disorder. Alzheimer’s disease is caused due to abnormal functioning of brain cells i.e. failure of synaptic transmission, resulting in the loss of cognitive functions. Some of the signs and symptoms of alzheimer’s disease are me…